Kathleen A. Rickard net worth and biography

Kathleen Rickard Biography and Net Worth

Insider of Verona Pharma

Dr Rickard has more than 25 years of experience in clinical research in respiratory medicine, industry, and management. Prior to joining Verona Pharma, Dr Rickard served in multiple roles at Aerocrine and subsequently Circassia, where she was instrumental in directing clinical and regulatory strategies for NIOX VERO, an airway inflammation test for managing asthma, across key markets such as the US, China, and Japan, as well as the rest of the world. Previously, Dr Rickard was Vice President Clinical Development and Medical Affairs of GlaxoSmithKline’s Respiratory Medicines Development Centre and, over a period of 15 years, held a number of other leadership positions in clinical development across GlaxoSmithKline’s global respiratory franchise. Dr Rickard received an MD from Hahnemann University Hospital, Philadelphia.

What is Kathleen A. Rickard's net worth?: The estimated net worth of Kathleen A. Rickard is at least $101.85 million as of May 3rd, 2024. Dr. Rickard owns 2,621,552 shares of Verona Pharma stock worth more than $101,847,295 as of November 21st. This net worth approximation does not reflect any other assets that Dr. Rickard may own. Additionally, Dr. Rickard receives an annual salary of $650,830.00 as Insider at Verona Pharma. Learn More about Kathleen A. Rickard's net worth.
How old is Kathleen A. Rickard?: Dr. Rickard is currently 66 years old. There are 4 older executives and no younger executives at Verona Pharma. Learn More on Kathleen A. Rickard's age.
What is Kathleen A. Rickard's salary?: As the Insider of Verona Pharma plc, Dr. Rickard earns $650,830.00 per year. There are 2 executives that earn more than Dr. Rickard. The highest earning executive at Verona Pharma is Dr. David S. Zaccardelli Pharm.D., President, CEO & Executive Director, who commands a salary of $1,270,000.00 per year. Learn More on Kathleen A. Rickard's salary.
How do I contact Kathleen A. Rickard?: The corporate mailing address for Dr. Rickard and other Verona Pharma executives is 3 MORE LONDON RIVERSIDE, LONDON X0, SE1 2RE. Verona Pharma can also be reached via phone at 011-44-0-2032834200 and via email at [email protected]. Learn More on Kathleen A. Rickard's contact information.
Has Kathleen A. Rickard been buying or selling shares of Verona Pharma?: Kathleen A. Rickard has not been actively trading shares of Verona Pharma within the last three months. Most recently, Kathleen A. Rickard sold 36,248 shares of the business's stock in a transaction on Friday, May 3rd. The shares were sold at an average price of $1.96, for a transaction totalling $71,046.08. Following the completion of the sale, the insider now directly owns 2,621,552 shares of the company's stock, valued at $5,138,241.92. Learn More on Kathleen A. Rickard's trading history.
Who are Verona Pharma's active insiders?: Verona Pharma's insider roster includes Lisa Deschamps (Director), David Ebsworth (Director), Martin Edwards (Director), Patrick Finn (Insider), Mark Hahn (CFO), Claire Poll (General Counsel), Kathleen Rickard (Insider), Anders Ullman (Director), and David Zaccardelli (CEO). Learn More on Verona Pharma's active insiders.
Are insiders buying or selling shares of Verona Pharma?: In the last year, Verona Pharma insiders bought shares 1 times. They purchased a total of 39,360 shares worth more than $188,928.00. In the last year, insiders at the sold shares 13 times. They sold a total of 1,178,192 shares worth more than $5,075,998.08. The most recent insider tranaction occured on November, 11th when CEO David Zaccardelli sold 2,400 shares worth more than $12,000.00. Insiders at Verona Pharma own 4.8% of the company. Learn More about insider trades at Verona Pharma.
Information on this page was last updated on 11/11/2024.

Kathleen A. Rickard Insider Trading History at Verona Pharma

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/3/2024	Sell	36,248	$1.96	$71,046.08	2,621,552
11/3/2023	Sell	58,752	$1.92	$112,803.84	2,840,640
8/7/2023	Sell	1,600	$2.47	$3,952.00	2,872,528
8/3/2023	Sell	50,600	$2.55	$129,030.00	2,902,072
8/1/2023	Sell	19,736	$2.68	$52,892.48	2,966,400
5/3/2023	Sell	28,752	$2.65	$76,192.80	2,971,136
5/1/2023	Sell	77,424	$2.58	$199,753.92	2,999,888
2/1/2023	Sell	89,960	$2.56	$230,297.60	3,106,064
8/2/2022	Sell	28,752	$0.70	$20,126.40	2,376,040
5/3/2022	Sell	28,752	$0.49	$14,088.48	2,461,224
4/11/2022	Sell	59,720	$0.54	$32,248.80	2,546,408
4/8/2022	Sell	112,800	$0.59	$66,552.00	2,606,128

Kathleen A. Rickard Buying and Selling Activity at Verona Pharma

Verona Pharma Company Overview

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. The company was incorporated in 2005 and is headquartered in London, the United Kingdom.

Today's Range

Now: $38.85

$37.61

$39.33

50 Day Range

MA: $33.12

$27.64

$39.87

2 Week Range

Now: $38.85

$11.39

$40.13

Volume

1,155,655 shs

Average Volume

1,099,138 shs

Market Capitalization

$3.11 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.42

📉 Warning: Market Crash Predicted - Secure Your Savings

From Behind the Markets | Ad

The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.

Take these 4 steps to protect your retirement here >>>

Kathleen Rickard Biography and Net Worth

What is Kathleen A. Rickard's net worth?

How old is Kathleen A. Rickard?

What is Kathleen A. Rickard's salary?

How do I contact Kathleen A. Rickard?

Has Kathleen A. Rickard been buying or selling shares of Verona Pharma?

Who are Verona Pharma's active insiders?

Are insiders buying or selling shares of Verona Pharma?